Report post

Does carsgen Therapeutics Holdings Limited (2171 HK) have company insights?

2171.HK does not have Company Insights Find the latest CARsgen Therapeutics Holdings Limited (2171.HK) stock quote, history, news and other vital information to help you with your stock trading and investing.

Who is carsgen Therapeutics?

CARsgen Therapeutics Holdings Limited, an investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United States.

How long has carsgen data been delayed?

Data delayed at least 15 minutes, as of Dec 27 2023 08:08 GMT. CARsgen Therapeutics Holdings Ltd is a China-based investment holding company principally engaged in discovering, developing and commercializing innovative chimeric antigen receptor (CAR)-T cell therapies.

The World's Leading Crypto Trading Platform

Get my welcome gifts